HCA Healthcare stock forecast
HCA Healthcare (2BH) Stock Forecast & Price Target
2BH Analyst Ratings
2BH Stock 12 Month Forecast
Average Price Target
€422.29▼(-6.84% Downside)Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Ann Hynes | Mizuho Securities | €517.13 | buy | 14.08%Upside | Reiterated | 11/15/26 | ||
| Kevin Fischbeck | Bank of America Securities | ― | hold | ― | Reiterated | 11/05/26 | ||
| Lance Wilkes | Bernstein | €386.49→€427.31 | hold | -5.73%Downside | Reiterated | 11/04/26 | ||
| Stephen Baxter | Wells Fargo | €345.66→€424.59 | hold | -6.33%Downside | Reiterated | 11/02/26 | ||
| Craig Hettenbach | Morgan Stanley | €344.76 | sell | -23.95%Downside | Assigned | 10/29/26 | ||
| Andrew Mok CFA | Barclays | €351.11→€363.81 | hold | -19.74%Downside | Reiterated | 10/29/26 | ||
| Ben Hendrix | RBC Capital | €450.00→€472.68 | buy | 4.27%Upside | Reiterated | 10/29/26 | ||
| Matthew Gillmor CFA | KeyBanc | €444.55 | buy | -1.93%Downside | Reiterated | 10/28/26 | ||
| Sean Dodge | BMO Capital | €449.09 | buy | -0.93%Downside | Reiterated | 10/28/26 | ||
| Michael Ha | Robert W. Baird | €356.55→€371.07 | hold | -18.14%Downside | Reiterated | 10/28/26 | ||
| Oppenheimer | €440.02 | buy | -2.93%Downside | Reiterated | 10/28/26 | |||
| Ryan Langston | TD Cowen | €417.34→€440.92 | buy | -2.73%Downside | Reiterated | 10/28/26 | ||
| Andrew Cooper | Raymond James | ― | hold | ― | Reiterated | 09/28/26 | ||
| Brian Tanquilut | Jefferies | €408.26 | buy | -9.94%Downside | Reiterated | 09/17/26 | ||
| Whit Mayo | Leerink Partners | ― | buy | ― | Reiterated | 09/17/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Ann HynesMizuho Securities | BuyReiterated€517.13 | 11/15/26 | 14.08%Upside | ||
| Kevin FischbeckBank of America Securities | HoldReiterated | 11/05/26 | ― | ||
| Lance WilkesBernstein | HoldReiterated€386.49→€427.31 | 11/04/26 | -5.73%Downside | ||
| Stephen BaxterWells Fargo | HoldReiterated€345.66→€424.59 | 11/02/26 | -6.33%Downside | ||
| Craig HettenbachMorgan Stanley | SellAssigned€344.76 | 10/29/26 | -23.95%Downside | ||
| Andrew Mok CFABarclays | HoldReiterated€351.11→€363.81 | 10/29/26 | -19.74%Downside | ||
| Ben HendrixRBC Capital | BuyReiterated€450.00→€472.68 | 10/29/26 | 4.27%Upside | ||
| Matthew Gillmor CFAKeyBanc | BuyReiterated€444.55 | 10/28/26 | -1.93%Downside | ||
| Sean DodgeBMO Capital | BuyReiterated€449.09 | 10/28/26 | -0.93%Downside | ||
| Michael HaRobert W. Baird | HoldReiterated€356.55→€371.07 | 10/28/26 | -18.14%Downside | ||
| BuyReiterated€440.02 | 10/28/26 | -2.93%Downside | |||
| Ryan LangstonTD Cowen | BuyReiterated€417.34→€440.92 | 10/28/26 | -2.73%Downside | ||
| Andrew CooperRaymond James | HoldReiterated | 09/28/26 | ― | ||
| Brian TanquilutJefferies | BuyReiterated€408.26 | 09/17/26 | -9.94%Downside | ||
| Whit MayoLeerink Partners | BuyReiterated | 09/17/26 | ― |
Best Analysts Covering HCA Healthcare
Copying Sarah James's trades and holding each position for 3 Months would result in 78.95% of your transactions generating a profit, with an average return of +8.16% per trade.
Copying Ann Hynes's trades and holding each position for 1 Year would result in 96.43% of your transactions generating a profit, with an average return of +22.18% per trade.
Copying Whit Mayo's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +54.89% per trade.
2BH Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 |
| Buy | 25 | 25 | 26 | 15 | 15 |
| Hold | 15 | 19 | 19 | 15 | 12 |
| Sell | 2 | 2 | 2 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 43 | 47 | 48 | 31 | 28 |
In the current month, 2BH has received 15 Buy Ratings, 12 Hold Ratings, and 1 Sell Ratings. 2BH average Analyst price target in the past 3 months is 422.29.
2BH Financial Forecast
2BH Earnings Forecast
Next quarter’s earnings estimate for 2BH is EUR 7.32 with a range of EUR 6.95 to EUR 7.62. The previous quarter’s EPS was EUR 6.46. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
2BH Sales Forecast
Next quarter’s sales forecast for 2BH is EUR 17.92B with a range of EUR 17.63B to EUR 18.16B. The previous quarter’s sales results were EUR 17.77B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

